Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-dose Mass Practice Intervention to Reduce ADL Disability in Dementia

NCT02356055 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.

NCT NCT02356055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02356055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-dose Mass Practice Intervention to Reduce ADL Disability in Dementia
Lead sponsor
University of Oklahoma
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2014
Completion date
November 30, 2016
Enrollment
32 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, dementia